Healthpeak Properties, Inc. (DOC) P/E Ratio History
Historical price-to-earnings valuation from 2013 to 2026
Loading P/E history...
DOC Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 6, 2026, Healthpeak Properties, Inc. (DOC) trades at a price-to-earnings ratio of 165.1x, with a stock price of $16.51 and trailing twelve-month earnings per share of $0.32.
The current P/E is 233% above its 5-year average of 49.5x. Over the past five years, DOC's P/E has ranged from a low of 20.6x to a high of 167.5x, placing the current valuation at the 95th percentile of its historical range.
Compared to the Real Estate sector median P/E of 24.1x, DOC trades at a 584% premium to its sector peers. The sector includes 170 companies with P/E ratios ranging from 1.1x to 165.1x.
Relative to the broader market, DOC commands a significant premium over the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our DOC DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
DOC P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $41B | 160.7 | - | +184% | |
| $150B | 154.2 | - | -11% | |
| $14B | 23.8 | 1.02Best | +25% | |
| $696M | 1.3Lowest | - | +284%Best | |
| $94M | 115.3 | - | -95% | |
| $504M | 227.9 | - | +134% | |
| $2B | 15.2 | - | +24% | |
| $4B | 24.2 | - | -4% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
DOC Historical P/E Data (2013–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q1 | $16.43 | $0.32 | 52.1x | +4% | |
| FY2025 Q4 | Wed Dec 31 2025 00:00:00 GM | $16.08 | $0.10 | 167.5x | +235% |
| FY2025 Q2 | Mon Jun 30 2025 00:00:00 GM | $17.51 | $0.23 | 75.4x | +51% |
| FY2025 Q1 | Mon Mar 31 2025 00:00:00 GM | $20.22 | $0.40 | 50.9x | +2% |
| FY2024 Q4 | $20.27 | $0.35 | 58.4x | +17% | |
| FY2024 Q3 | Mon Sep 30 2024 00:00:00 GM | $22.87 | $0.47 | 48.6x | -3% |
| FY2024 Q2 | Sun Jun 30 2024 00:00:00 GM | $19.60 | $0.47 | 41.6x | -17% |
| FY2024 Q1 | Sun Mar 31 2024 00:00:00 GM | $18.75 | $0.36 | 52.8x | +5% |
| FY2023 Q4 | Sun Dec 31 2023 00:00:00 GM | $19.80 | $0.56 | 35.1x | -30% |
| FY2023 Q3 | Sat Sep 30 2023 00:00:00 GM | $18.36 | $0.44 | 41.3x | -17% |
| FY2023 Q2 | Fri Jun 30 2023 00:00:00 GM | $20.10 | $0.97 | 20.6x | -59% |
| FY2023 Q1 | Fri Mar 31 2023 00:00:00 GM | $21.97 | $1.01 | 21.8x | -57% |
Average P/E for displayed period: 50.0x
Full DOC Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See DOC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs DOC Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare DOC vs WELL
Side-by-side business, growth, and profitability comparison vs Welltower Inc..
Start ComparisonDOC — Frequently Asked Questions
Quick answers to the most common questions about buying DOC stock.
Is DOC stock overvalued or undervalued?
DOC trades at 165.1x P/E, above its 5-year average of 49.5x. The 95th percentile ranking indicates a premium to historical valuation.
How does DOC's valuation compare to peers?
Healthpeak Properties, Inc. P/E of 165.1x compares to sector median of 24.1x. The premium reflects expected growth above peers.
What is DOC's PEG ratio?
DOC PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2013-2026.